U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT07453212) titled 'Microbiome-Focused Food Supplement for Evaporative Dry Eye Due to Meibomian Gland Dysfunction' on Feb. 13.
Brief Summary: Dry eye disease (DED) is a common chronic condition characterized by ocular surface discomfort and tear film instability. Evaporative DED associated with meibomian gland dysfunction (MGD) is a frequent phenotype and is often driven by inflammatory mechanisms. This randomized, double-blind, placebo-controlled trial evaluates whether an oral microbiome-focused food supplement improves dry eye symptoms and objective clinical signs compared with placebo over 8 weeks in adults with moderate evaporative DED due to MGD....